Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma.
Corre S, Tardif N, Mouchet N, Leclair HM, Boussemart L, Gautron A, Bachelot L, Perrot A, Soshilov A, Rogiers A, Rambow F, Dumontet E, Tarte K, Bessede A, Guillemin GJ, Marine JC, Denison MS, Gilot D, Galibert MD.
Corre S, et al. Among authors: gilot d.
Nat Commun. 2018 Nov 14;9(1):4775. doi: 10.1038/s41467-018-06951-2.
Nat Commun. 2018.
PMID: 30429474
Free PMC article.